Edition:
United States

Athenex Inc (ATNX.OQ)

ATNX.OQ on NASDAQ Stock Exchange Global Select Market

12.22USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$12.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
111,534
52-wk High
$20.90
52-wk Low
$9.87

Chart for

About

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company... (more)

Overall

Beta: --
Market Cap(Mil.): $1,076.79
Shares Outstanding(Mil.): 57.06
Dividend: --
Yield (%): --

Financials

  ATNX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -2.71 -- --
ROI: -- 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates